← Open Payments lookup

BATUL LUKMANJI: Open Payments

NPI 1568006674 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,329 in 168 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,545 · 2025 $3,329

Food & beverage: $3,314Education: $15
CompanyPaymentsAmount
Lundbeck LLC34$643
ABBVIE INC.14$311
Janssen Pharmaceuticals, Inc9$292
Alkermes, Inc.15$271
Otsuka America Pharmaceutical, Inc.12$232
Teva Pharmaceuticals USA, Inc.13$211
Supernus Pharmaceuticals, Inc.13$179
E.R. Squibb & Sons, L.L.C.9$159
Neurocrine BioSciences, Inc.5$154
Bausch Health US, LLC8$151

Products named: REXULTI, VRAYLAR, SPRAVATO, ARISTADA, Qelbree, COBENFY, INGREZZA, APLENZIN.

Industry payments across TX — which companies pay providers there.